Protara Therapeutics (TARA) Accumulated Depreciation (2013 - 2025)

Protara Therapeutics (TARA) has reported Accumulated Depreciation for 10 consecutive years, with $1.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 32.73% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (up 32.73% YoY), while the FY2025 annual figure was $1.5 million, up 32.73% from the prior year.
• Accumulated Depreciation improved to $1.5 million in Q4 2025 per TARA's latest filing, from $1.1 million in the prior quarter.
• Across five years, Accumulated Depreciation topped out at $1.5 million in Q4 2025 and bottomed at $824000.0 in Q4 2023.
• Historically, Accumulated Depreciation has averaged $1.1 million across 3 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2024 — Accumulated Depreciation jumped 34.22% — and 2025, when it surged 32.73%.
• Protara Therapeutics' Accumulated Depreciation stood at $824000.0 in 2023, then surged by 34.22% to $1.1 million in 2024, then soared by 32.73% to $1.5 million in 2025.
• Business Quant data shows TARA's Accumulated Depreciation at $1.5 million in Q4 2025, $1.1 million in Q4 2024, and $824000.0 in Q4 2023.